Moleculin Biotech, Inc. (MBRX) Capital expenditures 2016–2025
Moleculin Biotech, Inc. (MBRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2016: $21,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $13,000 | -89.5% |
| FY2023 | $124,000 | +85.1% |
| FY2022 | $67,000 | +252.6% |
| FY2021 | $19,000 | -94.9% |
| FY2020 | $376,000 | +623.1% |
| FY2019 | $52,000 | -87.5% |
| FY2018 | $417,000 | +1389.3% |
| FY2017 | $28,000 | +33.3% |
| FY2016 | $21,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice